Objective To describe the burden of bilateral neovascular age-related macular degeneration
(NV-AMD) on patient-reported functioning and health resource utilization. Methods A cross-…

This study aims to provide a rigorous estimate of the worldwide costs of visual impairment (VI),
and the associated health burden. The study used a prevalence-based model. …

PURPOSE: To demonstrate noninferiority of ranibizumab in combination with verteporfin
photodynamic therapy (PDT) versus ranibizumab monotherapy in patients with subfoveal …

… Alan F. Cruess has acted as a consultant for and received honoraria from Pfizer and
Novartis. Gergana Zlateva and Ronald Buggage are employees of Pfizer Inc. Xiao Xu, Caroline …

purpose. To compare the reliability, validity, and responsiveness of the Mars Letter Contrast
Sensitivity (CS) Test to the Pelli-Robson CS Chart. methods. One eye of 47 normal control …

Background: Retinopathy is a common complication of diabetes mellitus that if detected
early by regular retinal examinations can be treated; thus, blindness can be delayed or …

Methods An English-language literature search for the years 1997–2010 was conducted
using PubMed, EMBASE, the Cochrane Library, the National Guideline Clearing House, and …

Objective This study was conducted to provide the financial underpinnings necessary for
effective planning for the provision of eye health services in Canada. Canada is facing an aging …

Photodynamic therapy (PDT) with verteporfin has been used less comprehensively in the
treatment of exudative age‐related macular degeneration (AMD), and specifically of choroidal …

Background: Age-related macular degeneration (AMD) is a retinal disease affecting more
than 2 million Canadians over the age of 50. The neovascular form of AMD is responsible for …